Reply to Achieng and Riedel

J Infect Dis. 2019 Jan 1;219(1):167-169. doi: 10.1093/infdis/jiy437.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Heterocyclic Compounds, 3-Ring*
  • Integrases*
  • Oxazines
  • Piperazines
  • Pyridones
  • Serologic Tests

Substances

  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir
  • Integrases